AGENUS INC(NASDAQ:AGEN) stock News

AGEN Latest News, Press Relases and Analysis

All

Press Releases

20 days ago - By: Chartmill - Mentions: AAON OESX MLNK AI ...

Monday's pre-market session: top gainers and losers

5 days ago - By: Agenus Inc.

Update: Agenus Aug 27 Stakeholder Webcast—Transformative IO Updates, BOT/BAL Data, BATTMAN Preview, Zydus Partnership Momentum, and MiNK Spotlight

12 days ago - By: Agenus Inc.

Agenus to Unveil BOT/BAL Strategic Advancements, Key Milestones, and Future Outlook in Virtual Stakeholder Briefing on August 27, 2025

19 days ago - By: Zacks Investment Research - Mentions: INO

Agenus (AGEN) Reports Q2 Loss, Beats Revenue Estimates

20 days ago - By: The Motley Fool

Agenus Posts 48% Q2 Revenue Miss

20 days ago - By: Agenus Inc.

Agenus Announces Second Quarter 2025 Financial Results and Virtual Meeting to Discuss Strategic Progress

20 days ago - By: Benzinga - Mentions: SPHR ARQ DOLE TELA ...

Earnings Scheduled For August 11, 2025

23 days ago - By: Benzinga

Examining the Future: Agenus's Earnings Outlook

24 days ago - By: Zacks Investment Research - Mentions: GILD

Gilead Sciences (GILD) Tops Q2 Earnings and Revenue Estimates

25 days ago - By: Zacks Investment Research - Mentions: ANAB

AnaptysBio, Inc. (ANAB) Reports Q2 Loss, Tops Revenue Estimates

a month ago - By: Zacks Investment Research - Mentions: CVEO QS

Zacks.com featured highlights include QuantumScape, Civeo and Agenus

a month ago - By: Agenus Inc.

Agenus to Provide Corporate Update and Second Quarter 2025 Financial Report

a month ago - By: Agenus Inc.

Agenus to Highlight Emerging Survival Plateaus with Botensilimab/Balstilimab in Oral Presentation of Study in Refractory Patients Across Five Tumor Types at ESMO 2025

2 months ago - By: Agenus Inc.

Agenus’ BOT/BAL Achieves 42% Two-Year Survival in Refractory MSS CRC, Advances Toward Registration with FDA Alignment on Phase 3

2 months ago - By: Agenus Inc.

Agenus and Noetik Enter Collaboration to Develop AI-Enabled Predictive Biomarkers for BOT/BAL Using Foundation Models of Virtual Cell Biology

3 months ago - By: Yahoo Finance - Mentions: TIXT TINT TU CLVT

TELUS International (Cda) Inc. (TIXT) Surges 27% Following Buyout Proposal from TELUS Corporation

3 months ago - By: Yahoo Finance - Mentions: SNYR SYNR MKL BTG ...

Here is What You Need to Know Before Investing in Synergy CHC Corp. (SNYR)

3 months ago - By: Yahoo Finance - Mentions: HON ITGR TTEK FSS ...

Agenus Inc. (AGEN) Surges After Zydus Agreement, Analysts Upbeat on Stock

3 months ago - By: Agenus Inc.

Agenus Announces Virtual Annual Shareholders Meeting

3 months ago - By: Zacks Investment Research - Mentions: SRPT IMCR

FDA Grants Platform Technology Tag to Sarepta's Gene Therapy Vector

3 months ago - By: Yahoo Finance

Agenus and Zydus sign agreements for botensilimab and balstilimab

3 months ago - By: Agenus Inc.

Agenus and Zydus Lifesciences Enter $141M Strategic Collaboration to Advance BOT/BAL, Expand Zydus’ Biologics Manufacturing in the US

3 months ago - By: Agenus Inc.

Agenus Presents New Data at ASCO Highlighting Botensilimab’s Immune Activation in MSS Colorectal Cancer

3 months ago - By: Zacks Investment Research - Mentions: GSK ADPT SPRO

SPRO Stock Soars 245% on GSK-Partnered UTI Drug Meeting Study Goal

3 months ago - By: Zacks Investment Research - Mentions: MRNA ADPT

AGENUS INC (AGEN) Stock News

AGEN Latest News, Press Relases and Analysis

Monday's pre-market session: top gainers and losers

Update: Agenus Aug 27 Stakeholder Webcast—Transformative IO Updates, BOT/BAL Data, BATTMAN Preview, Zydus Partnership Momentum, and MiNK Spotlight

Agenus to Unveil BOT/BAL Strategic Advancements, Key Milestones, and Future Outlook in Virtual Stakeholder Briefing on August 27, 2025

Agenus (AGEN) Reports Q2 Loss, Beats Revenue Estimates

Agenus Posts 48% Q2 Revenue Miss

Agenus Announces Second Quarter 2025 Financial Results and Virtual Meeting to Discuss Strategic Progress

Earnings Scheduled For August 11, 2025

Examining the Future: Agenus's Earnings Outlook

Gilead Sciences (GILD) Tops Q2 Earnings and Revenue Estimates

AnaptysBio, Inc. (ANAB) Reports Q2 Loss, Tops Revenue Estimates

Zacks.com featured highlights include QuantumScape, Civeo and Agenus

Agenus to Provide Corporate Update and Second Quarter 2025 Financial Report

Agenus to Highlight Emerging Survival Plateaus with Botensilimab/Balstilimab in Oral Presentation of Study in Refractory Patients Across Five Tumor Types at ESMO 2025

Agenus’ BOT/BAL Achieves 42% Two-Year Survival in Refractory MSS CRC, Advances Toward Registration with FDA Alignment on Phase 3

Agenus and Noetik Enter Collaboration to Develop AI-Enabled Predictive Biomarkers for BOT/BAL Using Foundation Models of Virtual Cell Biology

TELUS International (Cda) Inc. (TIXT) Surges 27% Following Buyout Proposal from TELUS Corporation

Here is What You Need to Know Before Investing in Synergy CHC Corp. (SNYR)

Agenus Inc. (AGEN) Surges After Zydus Agreement, Analysts Upbeat on Stock

Agenus Announces Virtual Annual Shareholders Meeting

FDA Grants Platform Technology Tag to Sarepta's Gene Therapy Vector

Agenus and Zydus sign agreements for botensilimab and balstilimab

Agenus and Zydus Lifesciences Enter $141M Strategic Collaboration to Advance BOT/BAL, Expand Zydus’ Biologics Manufacturing in the US

Agenus Presents New Data at ASCO Highlighting Botensilimab’s Immune Activation in MSS Colorectal Cancer

SPRO Stock Soars 245% on GSK-Partnered UTI Drug Meeting Study Goal

U.S. Govt. Cancels $766M Funding Contract for Moderna's Bird Flu Shot